O15400
Gene name |
STX7 |
Protein name |
Syntaxin-7 |
Names |
|
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:8417 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for O15400
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-O15400-F1 | Predicted | AlphaFoldDB |
190 variants for O15400
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
rs1562340319 CA365687632 |
2 | S>C | No |
ClinGen Ensembl |
|
|
rs1479392994 CA365687630 |
3 | Y>N | No |
ClinGen TOPMed |
|
|
CA365687622 rs752794991 |
4 | T>A | No |
ClinGen ExAC gnomAD |
|
|
rs752794991 CA4003860 |
4 | T>S | No |
ClinGen ExAC gnomAD |
|
|
rs1310681876 CA365687612 |
5 | P>L | No |
ClinGen TOPMed gnomAD |
|
|
rs1354594719 CA365687615 |
5 | P>S | No |
ClinGen gnomAD |
|
|
CA4003858 rs760092171 |
6 | G>E | No |
ClinGen ExAC gnomAD |
|
|
rs369562473 CA4003857 |
11 | P>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA365687577 rs369562473 |
11 | P>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA4003854 rs1044057 |
12 | A>T | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA365687569 rs1562340254 |
13 | Q>E | No |
ClinGen Ensembl |
|
|
rs760207182 CA4003852 |
13 | Q>H | No |
ClinGen ExAC gnomAD |
|
|
rs1186044216 CA365687551 |
15 | A>D | No |
ClinGen gnomAD |
|
|
CA4003850 rs771903230 |
18 | I>M | No |
ClinGen ExAC gnomAD |
|
|
CA4003849 rs745880493 |
19 | S>F | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1364281387 CA365687521 |
20 | S>C | No |
ClinGen TOPMed |
|
|
CA4003848 rs773991133 |
21 | N>D | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4003847 rs770796111 |
22 | I>V | No |
ClinGen ExAC gnomAD |
|
|
CA4003846 rs372605930 |
26 | T>A | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA4003845 rs777920429 |
27 | Q>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs756340040 CA4003843 |
28 | C>Y | No |
ClinGen ExAC |
|
|
CA147979425 rs938409398 |
32 | I>M | No |
ClinGen Ensembl |
|
|
rs755045655 CA4003820 |
32 | I>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed |
|
CA4003819 COSM277518 rs747083359 |
34 | R>I | Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
|
CA365687397 rs1187133503 |
37 | N>S | No |
ClinGen gnomAD |
|
|
rs201355710 CA147979416 |
38 | Q>* | No |
ClinGen 1000Genomes |
|
|
CA365687390 rs1453899868 |
38 | Q>L | No |
ClinGen TOPMed gnomAD |
|
|
CA365687391 rs1453899868 |
38 | Q>R | No |
ClinGen TOPMed gnomAD |
|
|
rs758981256 CA4003817 |
39 | L>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1459272607 CA365687385 |
39 | L>V | No |
ClinGen gnomAD |
|
|
rs755811211 CA147979394 |
44 | D>A | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs755811211 CA4003814 |
44 | D>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA365687336 rs1201981928 |
47 | E>* | No |
ClinGen gnomAD |
|
|
CA278780 rs864309676 RCV000203258 |
53 | Q>H | No |
ClinGen ClinVar Ensembl dbSNP |
|
|
rs761610600 CA147977345 |
57 | Q>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs761610600 CA4003786 |
57 | Q>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA147977337 rs978366367 |
59 | T>A | No |
ClinGen Ensembl |
|
|
CA365687220 rs1484513282 |
61 | Q>* | No |
ClinGen gnomAD |
|
|
CA4003782 rs775613410 |
64 | K>R | No |
ClinGen ExAC gnomAD |
|
|
CA4003781 rs772313425 |
65 | E>Q | No |
ClinGen ExAC gnomAD |
|
|
CA365687175 rs1582653772 |
67 | D>E | No |
ClinGen Ensembl |
|
|
CA365687172 rs1222194923 |
68 | K>* | No |
ClinGen TOPMed gnomAD |
|
|
CA147977307 rs113421354 |
72 | E>G | No |
ClinGen Ensembl |
|
|
CA4003779 rs779517620 |
73 | F>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1237596474 CA365687125 COSM164678 |
74 | G>E | breast [Cosmic] | No |
ClinGen cosmic curated gnomAD |
| TCGA novel | 75 | S>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 76 | L>M | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs778068381 CA4003776 |
77 | P>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs778068381 CA365687108 |
77 | P>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs754646108 CA4003774 |
78 | T>I | No |
ClinGen ExAC |
|
|
CA147977254 rs772408320 |
79 | T>I | No |
ClinGen Ensembl |
|
|
rs4410755 CA147977259 |
79 | T>P | No |
ClinGen Ensembl |
|
|
CA4003772 rs779508895 |
80 | P>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4003771 rs757854094 |
81 | S>N | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA365687078 rs1384422744 |
83 | Q>K | No |
ClinGen gnomAD |
|
|
rs758050027 CA4003750 |
84 | R>C | No |
ClinGen ExAC gnomAD |
|
|
rs745375542 CA4003749 |
84 | R>H | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs758050027 CA4003751 |
84 | R>S | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 86 | R>M | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs778450295 CA4003748 |
88 | I>M | No |
ClinGen ExAC gnomAD |
|
|
rs1161993252 CA365687004 |
91 | D>V | No |
ClinGen gnomAD |
|
|
COSM2153252 rs773741919 CA4003747 |
92 | R>C | Variant assessed as Somatic; 0.0 impact. central_nervous_system [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
|
CA365686999 rs1365783081 |
92 | R>H | No |
ClinGen gnomAD |
|
|
rs903617367 CA147976781 |
96 | E>K | No |
ClinGen Ensembl |
|
|
CA365686955 rs1459624839 |
99 | T>A | No |
ClinGen TOPMed gnomAD |
|
|
CA147976779 rs202107481 |
100 | S>L | No |
ClinGen 1000Genomes |
|
|
rs1383897323 CA365686935 |
102 | T>I | No |
ClinGen TOPMed |
|
|
rs200115851 CA4003745 |
103 | N>D | No |
ClinGen ExAC gnomAD |
|
|
rs1461206436 CA365686920 |
104 | F>L | No |
ClinGen gnomAD |
|
|
CA4003743 rs752556609 |
107 | V>A | No |
ClinGen ExAC gnomAD |
|
|
rs755820982 CA4003744 |
107 | V>F | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4003742 rs767785107 |
110 | Q>* | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs767785107 CA365686883 |
110 | Q>K | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs770542402 CA147976743 |
111 | A>P | No |
ClinGen Ensembl |
|
|
CA365686873 rs1562324571 |
111 | A>V | No |
ClinGen Ensembl |
|
|
rs946492195 CA147976742 |
112 | A>V | No |
ClinGen TOPMed |
|
|
rs1193625974 CA365686867 |
113 | E>K | No |
ClinGen gnomAD |
|
|
CA4003739 rs763486294 |
114 | R>* | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4003738 rs763486294 |
114 | R>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4003737 rs773552054 |
114 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA365686856 rs1240326596 |
115 | E>Q | No |
ClinGen TOPMed |
|
|
CA4003735 rs770348151 |
118 | F>L | No |
ClinGen ExAC gnomAD |
|
|
CA4003734 rs748444335 |
119 | V>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA4003733 rs777045654 |
121 | R>* | No |
ClinGen ExAC gnomAD |
|
|
rs1042027145 CA147976701 |
121 | R>L | No |
ClinGen TOPMed |
|
|
rs1042027145 CA365686813 |
121 | R>Q | No |
ClinGen TOPMed |
|
| TCGA novel | 122 | V>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA365686799 rs1302570377 |
124 | A>T | No |
ClinGen gnomAD |
|
|
CA4003732 rs771698278 |
125 | S>G | No |
ClinGen ExAC gnomAD |
|
|
CA365686773 rs1372867837 |
128 | V>M | No |
ClinGen gnomAD |
|
|
CA147976061 rs778849596 |
136 | S>G | No |
ClinGen TOPMed |
|
|
rs1030879925 CA147976050 |
137 | S>* | No |
ClinGen TOPMed |
|
|
CA365686691 rs1273748303 |
138 | K>Q | No |
ClinGen TOPMed |
|
|
CA365686669 rs1374301510 |
141 | N>H | No |
ClinGen gnomAD |
|
|
rs1218785494 CA365686666 |
141 | N>S | No |
ClinGen gnomAD |
|
|
CA365686656 rs1436076870 |
143 | V>I | No |
ClinGen gnomAD |
|
|
rs776955652 CA4003714 |
145 | W>* | No |
ClinGen ExAC gnomAD |
|
|
CA365686634 rs1173683694 |
146 | E>* | No |
ClinGen gnomAD |
|
|
rs1307445408 CA365686627 |
147 | S>G | No |
ClinGen TOPMed |
|
|
rs201529204 CA4003696 |
149 | T>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs201529204 CA4003697 |
149 | T>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs369931134 CA4003694 |
151 | P>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA4003693 rs142460328 |
153 | V>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs775932086 CA4003692 |
154 | Q>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA365686567 rs775932086 |
154 | Q>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA147975539 rs540939045 |
155 | V>M | No |
ClinGen 1000Genomes TOPMed gnomAD |
|
|
CA4003691 rs147685020 |
157 | D>Y | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs772576698 CA4003690 |
158 | E>D | No |
ClinGen ExAC gnomAD |
|
|
rs1270865726 CA365686516 |
161 | T>I | No |
ClinGen gnomAD |
|
|
CA4003686 rs747692662 |
163 | D>H | No |
ClinGen ExAC gnomAD |
|
|
CA4003685 rs781228048 |
165 | L>F | No |
ClinGen ExAC gnomAD |
|
|
CA4003684 rs768719136 |
166 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs746775126 CA4003683 |
166 | R>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA365686486 rs768719136 |
166 | R>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA365686473 rs1379593472 |
168 | I>T | No |
ClinGen gnomAD |
|
|
CA4003681 rs758525798 |
170 | E>G | No |
ClinGen ExAC gnomAD |
|
|
CA365686377 rs148495140 COSM1073381 |
180 | A>D | Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated 1000Genomes ESP ExAC NCI-TCGA TOPMed gnomAD |
|
CA4003661 rs148495140 |
180 | A>V | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs777889796 CA4003659 COSM1073380 |
181 | D>G | Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
|
CA4003660 rs749370601 |
181 | D>Y | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs756560065 CA4003658 |
182 | I>T | No |
ClinGen ExAC gnomAD |
|
|
rs867860684 CA147974603 |
184 | D>N | No |
ClinGen Ensembl |
|
|
rs1232962590 CA365686344 |
185 | I>T | No |
ClinGen gnomAD |
|
|
rs1347746765 CA365686324 |
188 | I>L | No |
ClinGen gnomAD |
|
|
rs144864017 CA4003657 |
191 | D>G | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA gnomAD |
|
CA365686300 rs1299829879 |
191 | D>Y | No |
ClinGen gnomAD |
|
|
rs149848428 CA4003656 |
193 | G>R | No |
ClinGen ESP ExAC gnomAD |
|
|
CA4003654 rs751884427 |
194 | M>I | No |
ClinGen ExAC gnomAD |
|
|
rs1459709466 CA365686261 |
196 | I>M | No |
ClinGen TOPMed |
|
|
rs764975922 CA4003653 |
196 | I>T | No |
ClinGen ExAC gnomAD |
|
|
CA4003651 rs201892382 |
200 | G>R | No |
ClinGen ExAC gnomAD |
|
|
CA4003650 rs763736446 |
201 | D>N | No |
ClinGen ExAC gnomAD |
|
|
rs760131896 CA4003649 |
202 | V>G | No |
ClinGen ExAC gnomAD |
|
|
rs1407030823 CA365686213 |
203 | I>M | No |
ClinGen gnomAD |
|
|
CA365686216 rs1433554186 |
203 | I>T | No |
ClinGen gnomAD |
|
|
rs1251514865 CA365686195 |
204 | D>G | No |
ClinGen TOPMed |
|
|
rs774112518 CA4003625 |
205 | S>I | No |
ClinGen ExAC gnomAD |
|
|
rs770756173 CA4003624 |
206 | I>K | No |
ClinGen ExAC |
|
|
rs1582646331 CA365686178 |
207 | E>K | No |
ClinGen Ensembl |
|
|
rs1396711703 CA365686166 |
208 | A>G | No |
ClinGen gnomAD |
|
|
CA365686169 rs1314883777 |
208 | A>T | No |
ClinGen gnomAD |
|
|
rs762768849 CA4003623 |
209 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs773375272 CA4003622 |
210 | V>M | No |
ClinGen ExAC gnomAD |
|
|
CA4003621 rs769921819 |
211 | E>Q | No |
ClinGen ExAC gnomAD |
|
|
COSM1698008 rs748192631 CA4003620 |
212 | N>K | skin [Cosmic] | No |
ClinGen cosmic curated ExAC gnomAD |
|
CA365686133 rs1179604332 |
213 | A>G | No |
ClinGen TOPMed |
|
|
CA365686138 rs1163718645 |
213 | A>T | No |
ClinGen gnomAD |
|
|
CA4003619 rs530542469 |
214 | E>K | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs530542469 CA365686132 |
214 | E>Q | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs1164816730 CA365686115 |
216 | H>R | No |
ClinGen gnomAD |
|
|
CA4003616 rs780736873 |
217 | V>I | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 220 | A>E | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA365686086 rs1249089671 |
220 | A>G | No |
ClinGen gnomAD |
|
|
CA365686090 rs1372443650 |
220 | A>T | No |
ClinGen gnomAD |
|
|
rs1209640875 CA365686080 |
221 | N>S | No |
ClinGen TOPMed gnomAD |
|
|
rs1209640875 CA365686081 |
221 | N>T | No |
ClinGen TOPMed gnomAD |
|
|
rs970685870 CA147995765 |
222 | Q>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
|
rs750828676 CA4003614 |
223 | Q>R | No |
ClinGen ExAC gnomAD |
|
|
COSM3777123 CA365686048 COSM3777124 rs777413406 |
226 | R>K | Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
|
CA4003613 rs777413406 |
226 | R>T | No |
ClinGen ExAC gnomAD |
|
|
CA4003612 rs755786190 |
228 | A>V | No |
ClinGen ExAC gnomAD |
|
|
CA4003577 rs773669589 |
232 | R>C | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA4003576 rs746429926 |
232 | R>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA4003575 rs376336706 |
234 | S>F | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA365685890 rs1368781628 |
237 | T>N | No |
ClinGen gnomAD |
|
| TCGA novel | 237 | T>P | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1582643008 CA365685884 |
238 | L>P | No |
ClinGen Ensembl |
|
|
rs1269626265 CA365685878 |
239 | C>Y | No |
ClinGen gnomAD |
|
|
CA365685873 rs1228675641 |
240 | I>V | No |
ClinGen gnomAD |
|
|
CA4003573 rs372354234 |
241 | I>M | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1390827242 CA365685843 |
244 | I>M | No |
ClinGen TOPMed |
|
|
CA365685844 rs964239635 |
244 | I>S | No |
ClinGen TOPMed |
|
|
CA147993900 rs964239635 |
244 | I>T | No |
ClinGen TOPMed |
|
|
rs1385676566 CA365685840 |
245 | L>F | No |
ClinGen TOPMed |
|
|
rs1385676566 CA365685842 |
245 | L>I | No |
ClinGen TOPMed |
|
|
CA147993894 rs1017026752 |
247 | I>T | No |
ClinGen TOPMed gnomAD |
|
|
rs774205615 CA147993899 |
247 | I>V | No |
ClinGen Ensembl |
|
|
CA4003572 rs780651725 |
248 | G>E | No |
ClinGen ExAC gnomAD |
|
|
CA365685818 rs1342713051 |
249 | V>I | No |
ClinGen gnomAD |
|
|
CA365685810 rs1335463098 |
250 | A>G | No |
ClinGen TOPMed gnomAD |
|
|
CA365685809 rs1335463098 |
250 | A>V | No |
ClinGen TOPMed gnomAD |
|
|
rs746519125 CA4003570 |
251 | I>M | No |
ClinGen ExAC gnomAD |
|
|
rs368749896 CA4003571 |
251 | I>S | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
|
CA4003569 rs779598894 |
254 | L>F | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA365685787 rs779598894 |
254 | L>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1006072855 CA147993866 |
256 | I>V | No |
ClinGen TOPMed gnomAD |
|
|
CA4003567 rs375044570 |
258 | G>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1355809552 CA365685757 |
258 | G>V | No |
ClinGen TOPMed |
|
|
CA365685743 rs1187925289 |
260 | N>K | No |
ClinGen gnomAD |
|
|
CA365685741 rs1463356594 |
261 | H>N | No |
ClinGen gnomAD |
No associated diseases with O15400
19 GO annotations of cellular component
| Name | Definition |
|---|---|
| azurophil granule | Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid. |
| early endosome | A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways. |
| early endosome membrane | The lipid bilayer surrounding an early endosome. |
| endocytic vesicle | A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting. |
| endomembrane system | A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles. |
| endosome | A vacuole to which materials ingested by endocytosis are delivered. |
| extracellular exosome | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| immunological synapse | An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| late endosome | A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center. |
| lysosomal membrane | The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. |
| lysosome | A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. |
| perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| recycling endosome | An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane. |
| SNARE complex | A protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers. One well-characterized example is the neuronal SNARE complex formed of synaptobrevin 2, syntaxin 1a, and SNAP-25. |
| synaptic vesicle | A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane. |
| tertiary granule | A secretory granule that contains cathepsin and gelatinase and is readily exocytosed upon cell activation; found primarily in mature neutrophil cells. |
| vesicle | Any small, fluid-filled, spherical organelle enclosed by membrane. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| chloride channel inhibitor activity | Binds to and stops, prevents, or reduces the activity of a chloride channel. |
| SNAP receptor activity | Acting as a marker to identify a membrane and interacting selectively with one or more SNAREs on another membrane to mediate membrane fusion. |
| SNARE binding | Binding to a SNARE (soluble N-ethylmaleimide-sensitive factor attached protein receptor) protein. |
| syntaxin binding | Binding to a syntaxin, a SNAP receptor involved in the docking of synaptic vesicles at the presynaptic zone of a synapse. |
8 GO annotations of biological process
| Name | Definition |
|---|---|
| intracellular protein transport | The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell. |
| organelle assembly | The aggregation, arrangement and bonding together of a set of components to form an organelle. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane. |
| organelle localization | Any process in which an organelle is transported to, and/or maintained in, a specific location. |
| positive regulation of receptor localization to synapse | Any process that activates or increases the frequency, rate or extent of receptor localization to synapse. |
| positive regulation of T cell mediated cytotoxicity | Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity. |
| regulation of protein localization to plasma membrane | Any process that modulates the frequency, rate or extent of protein localization to plasma membrane. |
| vesicle docking | The initial attachment of a transport vesicle membrane to the target membrane, mediated by proteins protruding from the membrane of the vesicle and the target membrane. Docking requires only that the two membranes come close enough for these proteins to interact and adhere. |
| vesicle fusion | Fusion of the membrane of a transport vesicle with its target membrane. |
9 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P32854 | PEP12 | Syntaxin PEP12 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) | PR |
| Q3ZBT5 | STX7 | Syntaxin-7 | Bos taurus (Bovine) | PR |
| Q7KVY7 | Syx4 | Syntaxin-4 | Drosophila melanogaster (Fruit fly) | PR |
| Q12846 | STX4 | Syntaxin-4 | Homo sapiens (Human) | PR |
| P61266 | STX1B | Syntaxin-1B | Homo sapiens (Human) | PR |
| O75558 | STX11 | Syntaxin-11 | Homo sapiens (Human) | PR |
| Q16623 | STX1A | Syntaxin-1A | Homo sapiens (Human) | PR |
| O70439 | Stx7 | Syntaxin-7 | Mus musculus (Mouse) | PR |
| O70257 | Stx7 | Syntaxin-7 | Rattus norvegicus (Rat) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSYTPGVGGD | PAQLAQRISS | NIQKITQCSV | EIQRTLNQLG | TPQDSPELRQ | QLQQKQQYTN |
| 70 | 80 | 90 | 100 | 110 | 120 |
| QLAKETDKYI | KEFGSLPTTP | SEQRQRKIQK | DRLVAEFTTS | LTNFQKVQRQ | AAEREKEFVA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| RVRASSRVSG | SFPEDSSKER | NLVSWESQTQ | PQVQVQDEEI | TEDDLRLIHE | RESSIRQLEA |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DIMDINEIFK | DLGMMIHEQG | DVIDSIEANV | ENAEVHVQQA | NQQLSRAADY | QRKSRKTLCI |
| 250 | 260 | ||||
| IILILVIGVA | IISLIIWGLN | H |